T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% is a combination medication used primarily to treat inflammation and infections, often in ophthalmic preparations. Dexamethasone is a corticosteroid with potent anti-inflammatory properties, while Tobramycin is an aminoglycoside antibiotic effective against bacterial infections. This combination is used to provide both anti-inflammatory and antimicrobial effects.
The combination of Dexamethasone and Tobramycin is used in various clinical settings:
| Brand Name | T-Mycin Plus |
|---|---|
| Type | Ophthalmic Ointment |
| Weight | 0.1%+0.3% |
| Generic | Dexamethasone + Tobramycin |
| Manufacturer | Aristopharma Ltd. |
| Available in | English বাংলা |
Dexamethasone works by reducing inflammation and suppressing the immune response through its action on corticosteroid receptors. Tobramycin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing bacterial growth and replication.
The onset of action for T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% can vary:
When administered topically (e.g., as eye drops), the absorption of T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% occurs locally at the site of application. Systemic absorption is minimal, but some amount may be absorbed through the conjunctiva and the cornea into the bloodstream.
Dexamethasone is primarily metabolized by the liver and excreted via the urine. Tobramycin is mainly eliminated by the kidneys through renal excretion, with minimal metabolism occurring in the liver.
The dosage of T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% depends on the specific formulation and condition being treated:
T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% is commonly administered as eye drops. For correct administration:
Common side effects include:
Toxicity is rare when used as directed. Overuse or improper use may lead to significant side effects or complications such as increased intraocular pressure or secondary infections. Seek medical attention if symptoms of toxicity, such as severe pain or vision changes, occur.
Precautions include:
T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% may interact with other medications. Inform the healthcare provider of all concurrent medications, including over-the-counter drugs and supplements, to avoid potential interactions.
Use with caution in patients with:
Potential interactions include:
There are no specific food interactions reported with T-Mycin Plus Ophthalmic Ointment 0.1%+0.3%. Maintain a balanced diet to support overall health and treatment efficacy.
T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% should be used during pregnancy only if clearly needed and prescribed by a healthcare provider. The risks and benefits should be carefully considered, as corticosteroids and antibiotics can have implications for both the mother and fetus.
T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% is generally considered safe during lactation, but consult with a healthcare provider to ensure that the medication does not adversely affect breastfeeding or the infant.
Acute overdose is unlikely with topical use. In case of accidental ingestion or misuse, seek medical advice immediately. Overuse of the medication can lead to increased side effects and complications.
Contraindications include:
Follow the prescribed dosage and administration instructions carefully. Avoid sharing the medication and ensure that the product is used only for the indicated condition. Report any concerns or side effects to a healthcare provider promptly.
Store T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% according to the manufacturer's instructions, typically in a cool, dry place away from direct sunlight. Ensure the medication is kept out of reach of children and properly sealed to maintain efficacy.
The volume of distribution for T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% in topical applications is not typically measured. The medication acts locally at the site of application with minimal systemic distribution.
The half-life of Dexamethasone varies depending on the route of administration and individual factors but generally ranges from 3 to 5 hours. Tobramycin has a half-life of approximately 2 to 3 hours when administered systemically. The half-life of topical applications may differ.
Dexamethasone is cleared primarily by hepatic metabolism and renal excretion. Tobramycin is primarily cleared by renal excretion. The clearance rates may be influenced by individual patient factors and the specific formulation used.
See in details version T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% also T-Mycin Plus Ophthalmic Ointment 0.1%+0.3% in bangla
Brig. Gen. Dr. Golam Mohiuddin Chowdhury
Dental, Oral & Maxillofacial Surgery Specialist